Search
Phosphate ion
go.drugbank.com/drugs/DB14523InvestigationalSynonyms: Phosphate ionMixtures: PERIOLIMEL N4-600E İNFÜZYONLUK ELEKTROLİTLİ AMİNOASİT ÇÖZELTİSİ, GLUKOZ ÇÖZELTİSİ VE LİPİD EMÜLSİYONU, 1000 ML, PERIOLIMEL N4-600E İNFÜZYONLUK ELEKTROLİTLİ AMİNOASİT ÇÖZELTİSİ, GLUKOZ ÇÖZELTİSİ VE LİPİD EMÜLSİYONU, 1500 MLActelion-1
go.drugbank.com/drugs/DB05367ExperimentalActelion-1 is a tissue-targeting Endothelin Receptor Antagonist that has been discovered by Actelion Pharmaceuticals.
Mebhydrolin
go.drugbank.com/drugs/DB13808InvestigationalMebhydrolin is an antihistamine agent.[A275123]
Categories: Antihistamines for Systemic UseVatiquinone
go.drugbank.com/drugs/DB11917InvestigationalVatiquinone has been investigated for the treatment and prevention of Retinopathy, Rett Syndrome, Genetic Disease, Noise-induced Hearing Loss, and Methylmalonic Aciduria and Homocystinuria,Cblc Type.
Trepibutone
go.drugbank.com/drugs/DB13311ExperimentalCategories: Drugs for Functional Gastrointestinal Disorders3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide
go.drugbank.com/drugs/DB08092Experimental3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide is a solid. This compound belongs to the phenylmorpholines. … These are aromatic compounds containing a morpholine ring and a benzene ring linked to each other through a CC or a CN bond. This drug targets mitogen-activated protein kinase 14.
Synonyms: 3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamideBimokalner
go.drugbank.com/drugs/DB21717InvestigationalBimokalner is under investigation in clinical trial NCT06521190 (ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin). … Bimokalner is a small molecule drug. The usage of the INN stem '-kalner' in the name indicates that Bimokalner is a opener of calcium-activated (maxi-K) K+-channel.
Quisovalimab
go.drugbank.com/drugs/DB16482InvestigationalCategories: Experimental Unapproved Treatments for COVID-19Dociparstat sodium
go.drugbank.com/drugs/DB16481InvestigationalSynonyms: 2,3-o-Desulfated heparin (12000 da)Categories: Experimental Unapproved Treatments for COVID-19